Additionally, Toor et al. found that levels of CD4+CTLA-4+ T cells increased significantly in circulation of CRC patients with advanced stages, indicating a link between higher levels of CTLA-4+ Tregs and CRC progression [7]. Here, CTLA4 is linked to colorectal carcinoma.